-
European Cardiovascular Disease Statistics 2017
Wilkins E et al, (2017), European Heart Network
-
Cost-effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let's Prevent Diabetes cluster-randomised controlled trial.
J, Leal et al, (2017), BMJ Open
-
Economic impact of Early Intervention in Psychosis
services: results from a longitudinal retrospective controlled
study in England
Tsiachristas A. et al, (2016), BMJ Open
-
Models of care for the delivery of secondary fracture prevention after hip fracture: a health service cost, clinical outcomes and cost-effectiveness study within a region of England
Judge AD. et al, (2016), Health Services and Delivery Research
-
Economic burden of non-malignant blood disorders across Europe: a population-based cost study.
Luengo-Fernandez R. et al, (2016), The Lancet Haematology, 3, e371 - e378
-
Economic burden of malignant blood disorders across Europe: a population-based cost analysis.
Burns R. et al, (2016), The Lancet. Haematology, 3, e362 - e370
-
Economic burden of non-malignant blood disorders across Europe: a population-based cost study
Luengo-Fernandez, R et al, (2016), The Lancet Haematology
-
Economic burden of malignant blood disorders across Europe: a population-based cost analysis
Burns, R et al, (2016), The Lancet Haematology
-
Reducing social isolation in older people: a systematic review protocol
Filipa Landeiro et al, (2016), PROSPERO International prospective register of systematic reviews
-
The impact of social isolation on delayed hospital discharges of older hip fracture patients and associated costs.
Landeiro F. et al, (2016), Osteoporos Int, 27, 737 - 745
-
Impact of hip fracture on hospital care costs: a population-based study.
Leal J. et al, (2016), Osteoporos Int, 27, 549 - 558
-
Impact of hip fracture on hospital care costs: a population-based study
Leal J. et al, (2016), OSTEOPOROSIS INTERNATIONAL, 27, 549 - 558
-
Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening.
Scanlon PH. et al, (2015), Health Technol Assess, 19, 1 - 116
-
UK research spend in 2008 and 2012: comparing stroke, cancer, coronary heart disease and dementia.
Luengo-Fernandez R. et al, (2015), BMJ Open, 5
-
The impact of diabetes-related complications on healthcare costs: new results from the UKPDS (UKPDS 84).
Alva ML. et al, (2015), Diabet Med, 32, 459 - 466
-
IMPACT OF HIP FRACTURE ON HOSPITAL CARE COSTS: A POPULATION BASED STUDY
Leal J. et al, (2015), OSTEOPOROSIS INTERNATIONAL, 26, S55 - S55
-
Performance of the UKPDS outcomes model for prediction of myocardial infarction and stroke in the ADDITION-Europe trial cohort: does the ADDITION validation add up?
Gray A. et al, (2014), Value Health, 17, 895 - 896
-
The Burden of Health Care Costs Associated with Prostate Cancer in Ireland.
Burns RM. et al, (2014), Value Health, 17
-
Adopting an Evidence Synthesis Approach for Assessing Cost-Effectiveness of Screening Strategies for Prostate Cancer in Ireland.
Burns RM. et al, (2014), Value Health, 17, A552 - A553
-
Synthesis framework estimating prevalence of MCADD and sensitivity of newborn screening programme in the absence of direct evidence.
Leal J. et al, (2014), J Clin Epidemiol, 67, 1131 - 1138
-
Can delaying the onset of type 2 diabetes be cost-effective?
Gray AM. et al, (2014), DIABETOLOGIA, 57, S120 - S121
-
Estimating age and ethnic variation in the histological prevalence of prostate cancer to inform the impact of screening policies.
Leal J. et al, (2014), Int J Urol, 21, 786 - 792
-
Epidemiology of fragile X syndrome: a systematic review and meta-analysis.
Hunter J. et al, (2014), Am J Med Genet A, 164A, 1648 - 1658
-
Regional differences in the frequency of the c.985A>G ACADM mutation: findings from a meta-regression of genotyping and screening studies
Leal JJ. et al, (2014), Clinical Genetics: an international journal of genetics and molecular medicine
-
Economic burden of cancer across the European Union: a population-based cost analysis.
Luengo-Fernandez R. et al, (2013), Lancet Oncol, 14, 1165 - 1174
-
UKPDS Outcomes Model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82
Hayes AJ. et al, (2013), Diabetologia
-
Temporal validation of the UKPDS outcomes model using 10-year posttrial monitoring data.
Leal J. et al, (2013), Diabetes Care, 36, 1541 - 1546
-
UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?
Luengo-Fernandez R. et al, (2012), Eur J Neurol, 19, 149 - 154
-
An improved model to estimate lifetime health outcomes of patients with type 2 diabetes using 30-year follow-up data from the United Kingdom prospective diabetes study
Hayes AJ. et al, (2011), DIABETOLOGIA, 54, S8 - S8
-
Risk equations to predict life expectancy of people with Type 2 diabetes mellitus following major complications: a study from Western Australia.
Hayes AJ. et al, (2011), Diabet Med, 28, 428 - 435
-
Cost of dementia in the pre-enlargement countries of the European Union.
Luengo-Fernandez R. et al, (2011), J Alzheimers Dis, 27, 187 - 196
-
DNA testing for hypertrophic cardiomyopathy: a cost-effectiveness model.
Wordsworth S. et al, (2010), Eur Heart J, 31, 926 - 935
-
Bridging science and health policy in cardiovascular disease: focus on lipid management: A Report from a Session held during the 7th International Symposium on Multiple Risk Factors in Cardiovascular Diseases: Prevention and Intervention--Health Policy, in Venice, Italy, on 25 October, 2008.
Atella V. et al, (2009), Atheroscler Suppl, 10, 3 - 21
-
Development of life-expectancy tables for people with type 2 diabetes.
Leal J. et al, (2009), Eur Heart J, 30, 834 - 839
-
Estimating the cost of complications of diabetes in Australia using administrative health-care data.
Clarke P. et al, (2008), Value Health, 11, 199 - 206
-
Eliciting expert opinion for economic models: an applied example.
Leal J. et al, (2007), Value Health, 10, 195 - 203
-
Cost of cardiovascular diseases in the United Kingdom.
Luengo-Fernández R. et al, (2006), Heart, 92, 1384 - 1389
-
Is DNA testing for hypertrophic cardiomyopathy cost-effective?
Wordsworth S. et al, (2006), JOURNAL OF MEDICAL GENETICS, 43, S30 - S30
-
Economic burden of cardiovascular diseases in the enlarged European Union.
Leal J. et al, (2006), Eur Heart J, 27, 1610 - 1619
-
Perceptions of Risks for Diabetes-Related Complications in Type 2 Diabetes Populations. A Systematic Review.
Rouyard T. et al, Diabetic Medicine
-
How important is parameter uncertainty around the UK EQ-5D-3L value set when estimating treatment effects?
Gray A. et al, Joint meeting of the Health Economists' Study Group and the Collège des économistes de la santé Aix-en-Provence, France, 11-13 January 2012
-
Economic burden of bladder cancer across the European Union
Leal J. et al, European Urology
-
Cost-effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: a population based study
leal J. et al, Journal of Bone and Mineral Research
-
Cost effectiveness of a pragmatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the Let’s Prevent Diabetes cluster randomised controlled trial
Leal J. et al, BMJ Open
-
Cost effectiveness of a pragamatic structured education intervention for the prevention of type 2 diabetes: economic evaluation of data from the 'Let's Prevent Diabetes' cluster randomised controlled trial.
Leal, J et al, BMJ Open
-
Anti-osteoporosis medication prescriptions and incidence of subsequent fracture among primary hip fracture patients in England and Wales: an interrupted time-series analysis
Hawley S. et al, Journal of Bone and Mineral Research
